Literature DB >> 22878344

Interleukin-32: a predominantly intracellular proinflammatory mediator that controls cell activation and cell death.

Bas Heinhuis1, Mihai G Netea, Wim B van den Berg, Charles A Dinarello, Leo A B Joosten.   

Abstract

In this review, we will discuss the current knowledge on IL-32 and provide new insights regarding the biological function of IL-32. IL-32 is seen as a cytokine that can induce a range of proinflammatory mediators and contribute to autoimmune diseases, such as rheumatoid arthritis, however present knowledge demonstrates that IL-32 is not a classical cytokine. We present the history of this cytokine, the role of IL-32 in several diseases and discuss a possible novel role of intracellular IL-32 in cell homeostasis. Taken into account the observed biological functions of IL-32, it may belong to a class of cytokines, like IL-1α, IL-33, and IL-37, with both intracellular and extracellular functions.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22878344     DOI: 10.1016/j.cyto.2012.07.010

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  27 in total

Review 1.  Interleukin 30 to Interleukin 40.

Authors:  Jovani Catalan-Dibene; Laura L McIntyre; Albert Zlotnik
Journal:  J Interferon Cytokine Res       Date:  2018-10       Impact factor: 2.607

2.  IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression.

Authors:  Hanako Ohmatsu; Daniel Humme; Juana Gonzalez; Nicholas Gulati; Markus Möbs; Wolfram Sterry; James G Krueger
Journal:  Oncoimmunology       Date:  2016-05-05       Impact factor: 8.110

3.  IL-32 promotes angiogenesis.

Authors:  Claudia A Nold-Petry; Ina Rudloff; Yvonne Baumer; Menotti Ruvo; Daniela Marasco; Paolo Botti; Laszlo Farkas; Steven X Cho; Jarod A Zepp; Tania Azam; Hannah Dinkel; Brent E Palmer; William A Boisvert; Carlyne D Cool; Laima Taraseviciene-Stewart; Bas Heinhuis; Leo A B Joosten; Charles A Dinarello; Norbert F Voelkel; Marcel F Nold
Journal:  J Immunol       Date:  2013-12-11       Impact factor: 5.422

4.  IL-32γ promotes integrin αvβ6 expression through the activation of NF-κB in HSCs.

Authors:  Hongcan Liu; Xingfei Pan; Hong Cao; Xin Shu; Haixia Sun; Jianxi Lu; Jiayin Liang; Ka Zhang; Fengqin Zhu; Gang Li; Qi Zhang
Journal:  Exp Ther Med       Date:  2017-08-17       Impact factor: 2.447

5.  IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization.

Authors:  Hanako Ohmatsu; Daniel Humme; Nicholas Gulati; Juana Gonzalez; Markus Möbs; Mayte Suárez-Fariñas; Irma Cardinale; Hiroshi Mitsui; Emma Guttman-Yassky; Wolfram Sterry; James G Krueger
Journal:  Cancer Immunol Res       Date:  2014-06-17       Impact factor: 11.151

6.  Interleukin-32 production associated with biliary innate immunity and proinflammatory cytokines contributes to the pathogenesis of cholangitis in biliary atresia.

Authors:  A Okamura; K Harada; M Nio; Y Nakanuma
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

7.  Interleukin (IL)-32β-mediated CCAAT/enhancer-binding protein α (C/EBPα) phosphorylation by protein kinase Cδ (PKCδ) abrogates the inhibitory effect of C/EBPα on IL-10 production.

Authors:  Jeong-Woo Kang; Yun Sun Park; Man Sub Kim; Dong Hun Lee; Yesol Bak; Sun Young Ham; Soo Ho Park; Jin Tae Hong; Do-Young Yoon
Journal:  J Biol Chem       Date:  2013-06-30       Impact factor: 5.157

Review 8.  Novel insights into the biology of interleukin-32.

Authors:  Leo A B Joosten; Bas Heinhuis; Mihai G Netea; Charles A Dinarello
Journal:  Cell Mol Life Sci       Date:  2013-03-06       Impact factor: 9.261

9.  Upregulation of IL-32 Isoforms in Virologically Suppressed HIV-Infected Individuals: Potential Role in Persistent Inflammation and Transcription From Stable HIV-1 Reservoirs.

Authors:  Sarah M Zaidan; Louise Leyre; Rémi Bunet; Etienne Larouche-Anctil; Isabelle Turcotte; Mohamed Sylla; Annie Chamberland; Carl Chartrand-Lefebvre; Petronela Ancuta; Jean-Pierre Routy; Jean-Guy Baril; Benoit Trottier; Paul MacPherson; Sylvie Trottier; Marianne Harris; Sharon Walmsley; Brian Conway; Alexander Wong; Réjean Thomas; Robert C Kaplan; Alan L Landay; Madeleine Durand; Nicolas Chomont; Cécile L Tremblay; Mohamed El-Far
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12-15       Impact factor: 3.731

10.  Increased plasma interleukin-32 expression in patients with neuromyelitis optica.

Authors:  Honghao Wang; Kai Wang; Conghui Wang; Fangcheng Xu; Wei Qiu; Xueqiang Hu
Journal:  J Clin Immunol       Date:  2012-11-21       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.